Page last updated: 2024-08-21

3-hydroxyflavone and Airflow Obstruction, Chronic

3-hydroxyflavone has been researched along with Airflow Obstruction, Chronic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bodas, M; Brucia, K; Pehote, G; Vij, N1
Bast, A; Geraets, L; Hageman, GJ; Manders, RJ; Moonen, HJ; Pennings, HJ; van Loon, LJ; Weseler, AR; Wouters, EF1

Other Studies

2 other study(ies) available for 3-hydroxyflavone and Airflow Obstruction, Chronic

ArticleYear
Cigarette Smoke Exposure Inhibits Bacterial Killing via TFEB-Mediated Autophagy Impairment and Resulting Phagocytosis Defect.
    Mediators of inflammation, 2017, Volume: 2017

    Topics: Animals; Autophagy; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Cystic Fibrosis Transmembrane Conductance Regulator; Flavonoids; Flavonols; Macrophages; Mice; Nicotiana; Phagocytosis; Pulmonary Disease, Chronic Obstructive; RAW 264.7 Cells; Smoke

2017
Poly (ADP-ribose) polymerase-1-inhibiting flavonoids attenuate cytokine release in blood from male patients with chronic obstructive pulmonary disease or type 2 diabetes.
    The Journal of nutrition, 2009, Volume: 139, Issue:5

    Topics: Aged; Chromones; Cytokines; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Flavonoids; Flavonols; Humans; Interleukin-1; Interleukin-10; Interleukin-8; Lipopolysaccharides; Male; Middle Aged; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Pulmonary Disease, Chronic Obstructive; Tumor Necrosis Factor-alpha

2009